chr17-7592778-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004860.4(FXR2):c.1645C>T(p.Arg549Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000614 in 1,613,550 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R549G) has been classified as Uncertain significance.
Frequency
Consequence
NM_004860.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FXR2 | NM_004860.4 | c.1645C>T | p.Arg549Cys | missense_variant | 14/17 | ENST00000250113.12 | |
FXR2 | XM_047437106.1 | c.1645C>T | p.Arg549Cys | missense_variant | 14/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FXR2 | ENST00000250113.12 | c.1645C>T | p.Arg549Cys | missense_variant | 14/17 | 1 | NM_004860.4 | P1 | |
FXR2 | ENST00000704984.1 | c.1864C>T | p.Arg622Cys | missense_variant | 14/17 | ||||
MPDU1 | ENST00000423172.6 | c.*306G>A | 3_prime_UTR_variant | 6/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152004Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000114 AC: 28AN: 246088Hom.: 0 AF XY: 0.0000746 AC XY: 10AN XY: 134048
GnomAD4 exome AF: 0.0000370 AC: 54AN: 1461428Hom.: 0 Cov.: 32 AF XY: 0.0000303 AC XY: 22AN XY: 726992
GnomAD4 genome AF: 0.000296 AC: 45AN: 152122Hom.: 0 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2023 | The c.1645C>T (p.R549C) alteration is located in exon 14 (coding exon 14) of the FXR2 gene. This alteration results from a C to T substitution at nucleotide position 1645, causing the arginine (R) at amino acid position 549 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at